name
Galectin Therapeutics Inc.homepage url
galectintherapeutics.comcountry
United Statesemployee count
14sector
Healthcareindustry
Biotechnology
Description
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
